The role of the glucagon‐FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition

Documenti analoghi

• Oral TIX100 protects against obesity‐associated glucose intolerance and diet‐induced adiposity
  di: SeongHo Jo, et al.
  Pubblicazione: (2025)
• CHIP mediates glucagon action on hepatic glucose production via regulating Smad3 ubiquitination
  di: Quan Pan, et al.
  Pubblicazione: (2025)
• The role of gut–islet axis in pancreatic islet function and glucose homeostasis
  di: Qi Chen, et al.
  Pubblicazione: (2025)
• Risks of peri‐ and postoperative complications with glucagon‐like peptide‐1 receptor agonists
  di: David C. Klonoff, et al.
  Pubblicazione: (2024)
• Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
  di: Irl B. Hirsch, et al.
  Pubblicazione: (2024)